Tempus is a data-driven precision medicine company bringing the power of data and artificial intelligence to healthcare. Tempus is a technology company advancing precision medicine through the ...

The latest price target for Tempus AI (NASDAQ:TEM) was reported by Needham on April 24, 2025. The analyst firm set a price target for $70.00 expecting TEM to rise to within 12 months (a possible ...

Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal ...

When it comes to shares of Tempus AI (NASDAQ: TEM), many may feel like they're standing on a dock watching the stock sail off to the horizon.It's understandable if you identify with this. After ...

In other recent news, Tempus AI has seen several significant developments. The company has upgraded its stock rating and raised the price target to $74, according to TD Cowen. This upgrade follows ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, has announced the launch of Notetaker ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, is leveraging its TIME Network to expand ...